Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLEAR phase 2 trial of lesigercept in chronic spontaneous urticaria
ChiCTR2600130938Phase 2Recruiting
- Sponsor
- Southern Medical University Dermatology Hospital
- Start
- Dec 2025
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of YH35324 in chronic idiopathic urticaria (CIU) (3 arms), sponsored by Southern Medical University Dermatology Hospital. Primary endpoint: Change from baseline in UAS7 score at Week 12. Started Dec 2025; status: recruiting.
02
Drugs
YH35324
03
Conditions
chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on ChiCTR2600130938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600130938.